ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
6,144.15
0.24%
US Tech 100
21,532.00
-0.23%
다우존스 지수
44,627.59
0.16%
Bitcoin
97,200.31
0.59%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ

  6. CRISPR Therapeutics AG (CRSP) 시세

CRISPR Therapeutics AG

CRISPR Therapeutics AG (CRSP)

NASDAQ
53.02
0.80
(1.53%)
마감 20 2월 6:00AM
15분 지연
52.50
-0.52
( -0.98% )
시간외 단일가: 6:21PM
15분 지연

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

프리미엄

주요 통계 및 세부정보

가격
52.50
매수가
52.10
매도가
52.90
거래량
1,476
0.00 일간 변동폭 0.00
36.52 52주 범위 91.10
market_cap
4.503B
전일 종가
53.02
개장가
-
최근 거래 시간
10
@
52.28
마지막 거래 시간
18:21:23
재정 규모
-
VWAP
-
평균 볼륨(3m)
2,167,145
발행 주식
85,774,474
배당수익률
-
주가수익률
-29.61
주당순이익(EPS)
-1.79
매출
371.21M
순이익
-153.61M

CRISPR Therapeutics AG 정보

CRISPR Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specifi... CRISPR Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. CRISPR's most advanced pipeline candidate, CTX001, is in collaboration with Vertex Pharmaceuticals and targets sickle cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is progressing additional gene editing programs for immuno-oncology, as well as a stem cell-derived therapy for the treatment of Type 1 diabetes. 더 보기

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
www.crisprtx.com
본부
Zug, Che
설립됨
-
CRISPR Therapeutics AG is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker CRSP. The last closing price for CRISPR Therapeutics was US$53.02. Over the last year, CRISPR Therapeutics shares have traded in a share price range of US$ 36.52 to US$ 91.10.

CRISPR Therapeutics currently has 85,774,474 shares in issue. The market capitalisation of CRISPR Therapeutics is US$4.55 billion. CRISPR Therapeutics has a price to earnings ratio (PE ratio) of -29.61.

CRISPR Therapeutics (CRSP) 옵션 플로우 요약

전체 옵션 플로우 보기

전체 흐름

강세

순 프리미엄

4M

Calls / Puts

2,075.00%

매수 / 매도

196.43%

OTM / ITM

155.88%

Sweeps 비율

2.30%

CRSP 최신 뉴스

추가 뉴스

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
11 시간 전
CRSP (1.53%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
11 시간 전
CRSP (1.53%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
19 2월 2025
CRSP (1.53%)

Form 8-K - Current report
Edgar (US Regulatory)
12 2월 2025
CRSP (1.53%)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
18.820.137299771243.755.8842.2493038150.52545261CS
47.9817.924528301944.5255.8838.28261420545.24137226CS
121.52.941176470595155.8836.52216714544.36859502CS
262.835.6976041876449.6759.069336.52165716146.12407384CS
52-27.65-34.497816593980.1591.136.52154073453.76277976CS
156-4.59-8.0399369416757.0991.136.52153273857.64882046CS
260-5.58-9.6074380165358.08220.2132147351377.14633673CS

CRSP - Frequently Asked Questions (FAQ)

What is the current CRISPR Therapeutics share price?
The current share price of CRISPR Therapeutics is US$ 52.50
How many CRISPR Therapeutics shares are in issue?
CRISPR Therapeutics has 85,774,474 shares in issue
What is the market cap of CRISPR Therapeutics?
The market capitalisation of CRISPR Therapeutics is USD 4.55B
What is the 1 year trading range for CRISPR Therapeutics share price?
CRISPR Therapeutics has traded in the range of US$ 36.52 to US$ 91.10 during the past year
What is the PE ratio of CRISPR Therapeutics?
The price to earnings ratio of CRISPR Therapeutics is -29.61
What is the cash to sales ratio of CRISPR Therapeutics?
The cash to sales ratio of CRISPR Therapeutics is 12.25
What is the reporting currency for CRISPR Therapeutics?
CRISPR Therapeutics reports financial results in USD
What is the latest annual turnover for CRISPR Therapeutics?
The latest annual turnover of CRISPR Therapeutics is USD 371.21M
What is the latest annual profit for CRISPR Therapeutics?
The latest annual profit of CRISPR Therapeutics is USD -153.61M
What is the registered address of CRISPR Therapeutics?
The registered address for CRISPR Therapeutics is BAARERSTRASSE 14, ZUG, 6300
What is the CRISPR Therapeutics website address?
The website address for CRISPR Therapeutics is www.crisprtx.com
Which industry sector does CRISPR Therapeutics operate in?
CRISPR Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
MNDRMobile health Network Solutions
US$ 0.5033
(52.84%)
6.38M
MBCNMiddlefield Banc Corporation
US$ 37.00
(42.80%)
209
XOSXos Inc
US$ 4.35
(38.98%)
554.98k
PMTSCPI Card Group Inc
US$ 41.00
(35.18%)
203
TSBKTimberland Bancorp Inc
US$ 39.99
(31.55%)
3
HWBKHawthorn Bancshares Inc
US$ 20.01
(-41.13%)
7
INVInnventure Inc
US$ 7.00
(-36.07%)
200
HTBIHomeTrust Bancshares Inc
US$ 26.01
(-30.99%)
6
SNFCASecurity National Financial Corporation
US$ 9.30
(-30.08%)
204
GYREGyre Therapeutics Inc
US$ 9.01
(-25.78%)
4
MNDRMobile health Network Solutions
US$ 0.5033
(52.84%)
6.38M
ADTXAditxt Inc
US$ 0.1059
(-17.65%)
5.88M
CYCUCycurion Inc
US$ 4.06
(0.00%)
1.82M
BHATBlue Hat Interactive Entertainment Technology
US$ 0.0655
(5.31%)
1.71M
DGLYDigital Ally Inc
US$ 0.0881
(-6.28%)
706.41k

CRSP Discussion

게시물 보기
TechandBio TechandBio 2 일 전
Added a chunk today to my stash average is now 42.00

$CRSP
👍️0
TechandBio TechandBio 2 일 전
Nice pre market action!

Very deep pipeline with a mega partner VRTX

$CRSP
👍️0
TechandBio TechandBio 5 일 전
Starting to turn the corner now!

Glad I re-loaded the low 40's

$CRSP
👍️ 1
jondoeuk jondoeuk 1 월 전
Anticipated 2025 milestones https://www.globenewswire.com/news-release/2025/01/13/3008308/0/en/CRISPR-Therapeutics-Highlights-Strategic-Priorities-and-Anticipated-2025-Milestones.html
👍️ 1
jondoeuk jondoeuk 1 월 전
Link to the webcast https://jpmorgan.metameetings.net/events/healthcare25/sessions/58421-crispr-therapeutics/webcast/general_signin?gpu_only=true&kiosk=true+%5Bjpmorgan.metameetings.net%5D
👍️ 1
jondoeuk jondoeuk 1 월 전
They will present at the 43rd Annual J.P. Morgan Healthcare Conference (Jan 14, at 2:15 PM PST).
👍️ 1
PonkenPlonken PonkenPlonken 2 월 전
cheap cheap
👍️ 1
jondoeuk jondoeuk 2 월 전
The PR https://www.globenewswire.com/news-release/2024/12/09/2993974/0/en/CRISPR-Therapeutics-Presents-Data-at-the-2024-American-Society-of-Hematology-ASH-Annual-Meeting.html

Poster https://ir.crisprtx.com/static-files/12114290-21a6-4544-9cb7-de4fe2852e94
👍️0
PonkenPlonken PonkenPlonken 3 월 전
Neglected ugly duckling. $NTLA, $VERV & $CRBU now do trials outside of the US.... Maybe sentiment change is on the horizon -- see below

"The CBER director also apologized for “mistakes” in how the FDA handled early work for in vivo gene therapies, which “led to offshoring of some of the trials.”"
https://endpts.com/fda-vaccine-chief-peter-marks-pledges-to-stay-as-long-as-hes-welcome/#:~:text=The%20CBER%20director%20also%20apologized,%E2%80%9Cit%20is%20really%20important.%E2%80%9D

CHEAP CHEAP
SRPT and BMS announcing nice CRISPR deals with ARWR and PRME should help this too!
👍️0
jondoeuk jondoeuk 3 월 전
CTX130 data in R/R T-cell lymphomas (peripheral T-cell lymphoma or cutaneous T-cell lymphoma) https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(24)00508-4/abstract

The ORR was 46.2%. Of those treated at DL3 and higher, the ORR was 51.6%.
👍️ 1
PonkenPlonken PonkenPlonken 3 월 전
so so so undervalued and misunderstood i believe...... frankly just cheap
https://x.com/RNAiAnalyst/status/1859876294487363651
👍️ 1
jondoeuk jondoeuk 3 월 전
They now have the ability to put in eight to nine edits. So it is a single cassette that expresses the CAR, can express a cytokine and has an shRNA-like approach to knock down genes. So there's no theoretical limit as to the number of edits, but there may be marginal utility beyond a certain point.

Hopefully, they look to improve donor selection, cell selection and manufacturing, as all could increase efficacy.
👍️ 1
jondoeuk jondoeuk 3 월 전
ASH abstract https://ash.confex.com/ash/2024/webprogram/Paper203563.html
👍️0
jondoeuk jondoeuk 3 월 전
Q3 business update and financial results https://www.globenewswire.com/news-release/2024/11/05/2974996/0/en/CRISPR-Therapeutics-Provides-Business-Update-and-Reports-Third-Quarter-2024-Financial-Results.html
👍️0
Monksdream Monksdream 4 월 전
CRSP 10Q 11/5
👍️0
Monksdream Monksdream 4 월 전
CRSP under $50
👍️0
jondoeuk jondoeuk 4 월 전
OT: In this Dr. Urnov, PhD, laid out the urgent case for major reform in the regulatory appraisal of clinical therapies involving CRISPR gene therapies https://www.liebertpub.com/doi/10.1089/crispr.2024.0082
👍️ 1
TechandBio TechandBio 5 월 전
CRSP will climb tremendously over the years.
SMMT went from $1.00-30.00+ this year cancer drug superior to Mercks Keytruda
ICCM company being over looked that kills cancers by freezing them 97% non recurrence rate for breast cancer after 5 years and superior data to lung cancer safe cryoblation is done in less than hour.
https://www.prnewswire.com/il/news-releases/icecure-medical-reports-positive-topline-results-from-ice3-cryoablation-breast-cancer-study-achievement-of-96-39-recurrence-free-rate-brings-company-one-step-closer-to-providing-women-a-non-surgical-alternative-to-lumpectomy-302092712.html

https://www.prnewswire.com/il/news-releases/icecure-medical-reports-positive-topline-results-from-ice3-cryoablation-breast-cancer-study-achievement-of-96-39-recurrence-free-rate-brings-company-one-step-closer-to-providing-women-a-non-surgical-alternative-to-lumpectomy-302092712.html
👍️0
Monksdream Monksdream 5 월 전
Buy range again thanks a bunch
👍️0
Monksdream Monksdream 5 월 전
Buy range again thanks a bunch
👍️0
OldAIMGuy OldAIMGuy 5 월 전
Hi MD,
Here's a little longer view:


This might also be a cyclical low here. But, most of 2024 has shown severe distribution of shares until about the last month. That, at least, seems to be flattening out.
Best wishes,
OAG
👍️0
Monksdream Monksdream 5 월 전
CRSP trend since February remains bearish
👍️0
jondoeuk jondoeuk 7 월 전
Q2 results https://finance.yahoo.com/news/crispr-therapeutics-provides-business-reports-200100452.html
👍️0
lambchops lambchops 7 월 전
Hey Monk, Hopefully you bought some shares on Friday@ Sold at 10% discount!

LC

CRISPR!!!
👍️0
Monksdream Monksdream 7 월 전
CRSP under $75
👍️0
TechandBio TechandBio 7 월 전
Crispr added some $120 Vertical debit spreads in 2026

$CRSP
👍️ 1
axelvento axelvento 9 월 전
I agree.....solid company$$$$$$$$
👍️0
Monksdream Monksdream 9 월 전
It may take some time for CRSP returns to a $200 price tag
The same could be said for hundreds of other stocks that soared during Covid mania
Since then the stock has rallied from low points
With all that money the company has to do incredible things with its biotechnology the stock isn’t going to zero
👍️ 1
axelvento axelvento 9 월 전
Strong balance sheet with approximately $2.1 billion in cash, cash equivalents, and marketable securities as of March 31, 2024

https://finance.yahoo.com/news/crispr-therapeutics-provides-business-reports-200000059.html
👍️0
jondoeuk jondoeuk 9 월 전
(OT): A new AI paper from Princeton and Stanford https://www.biorxiv.org/content/10.1101/2024.04.25.591003v2.full

CRISPR-GPT demonstrated a marked improvement in gene-editing experiments, increasing the accuracy of target gene modifications by up to 30% compared to conventional methods. In validation tests, it achieved a specificity rate exceeding 95%, with a significant reduction in off-targets. The system also reduced the time required to design and plan experiments by approximately 40%, streamlining the workflow for researchers.
👍️0
jondoeuk jondoeuk 9 월 전
Business Update and Q1 Financial Results https://uk.finance.yahoo.com/news/crispr-therapeutics-provides-business-reports-200000300.html
👍️0
jondoeuk jondoeuk 9 월 전
Highlights (plus new programs utilising in vivo gene editing) https://finance.yahoo.com/news/crispr-therapeutics-highlights-asgct-oral-110000066.html
👍️0
jondoeuk jondoeuk 10 월 전
https://www.globenewswire.com/news-release/2024/04/22/2867236/0/en/CRISPR-Therapeutics-to-Present-Oral-Presentation-at-the-American-Society-of-Gene-Cell-Therapy-ASGCT-2024-Annual-Meeting.html

EDIT is also pursuing myocilin-related glaucoma https://www.globenewswire.com/news-release/2024/04/22/2867244/0/en/Editas-Medicine-to-Present-Pre-clinical-Data-Demonstrating-Progression-of-in-vivo-Medicines-Pipeline-at-the-American-Society-of-Gene-and-Cell-Therapy-Annual-Meeting.html
👍️0
OldAIMGuy OldAIMGuy 10 월 전
StockCharts 3 year history with 20% ZigZag reversals................



CRSP seems to be suffering from lack of 'sponsorship' in that the stock has not shown "accumulation" trend along with the price rally since last year's October Low. There's been volume, but not accumulation bias.

Best wishes,
OAG
👍️0
OldAIMGuy OldAIMGuy 10 월 전
Hi MD,
CRSP is now down around 1/3 from its February high. The price is where I usually start to accumulate more shares.

Best wishes,
OAG
👍️0
Monksdream Monksdream 10 월 전
CRSP over $30
👍️0
jondoeuk jondoeuk 11 월 전
Upcoming https://uk.finance.yahoo.com/news/crispr-therapeutics-present-american-society-120000624.html
👍️0
Monksdream Monksdream 12 월 전
CRSP new 52 week high
👍️0
Monksdream Monksdream 12 월 전
Early Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
👍️0
Monksdream Monksdream 1 년 전
CRSP new 52 week high
👍️ 1
Monksdream Monksdream 1 년 전
CRSP new 52 week high
👍️ 1
jondoeuk jondoeuk 1 년 전
They entered into an investment agreement for the sale of ~$280 million of its shares to a select group of institutional investors in a registered direct offering, at $71.5 apiece. The financing is being led by EcoR1 Capital and SR One with participation from existing investors and a healthcare specialist investor https://finance.yahoo.com/news/crispr-therapeutics-announces-280-million-133000932.html
👍️0
jondoeuk jondoeuk 1 년 전
EU approval https://finance.yahoo.com/news/european-commission-approves-first-crispr-065900771.html
👍️ 1
Monksdream Monksdream 1 년 전
Didn’t tank like BLUE
Recovered


More analysis from Nanolyze

👍️0
Monksdream Monksdream 1 년 전
So there has been some discussion since my last post
More in this podcast
🌈 1 🍆 1
jondoeuk jondoeuk 1 년 전
Around two months ahead of expectations https://www.globenewswire.com/news-release/2024/01/16/2810298/0/en/CRISPR-Therapeutics-Announces-U-S-Food-and-Drug-Administration-FDA-Approval-of-CASGEVY-exagamglogene-autotemcel-for-the-Treatment-of-Transfusion-Dependent-Beta-Thalassemia.html
👍️ 1
jondoeuk jondoeuk 1 년 전
Strategic Priorities and 2024 Outlook https://finance.yahoo.com/news/crispr-therapeutics-highlights-strategic-priorities-120000043.html
👍️0
jondoeuk jondoeuk 1 년 전
Webcast link https://jpmorgan.metameetings.net/events/healthcare24/sessions/49607-crispr-therapeutics-inc/webcast/general_signin?gpu_only=true&kiosk=true
👍️ 1
jondoeuk jondoeuk 1 년 전
Upcoming https://uk.finance.yahoo.com/news/crispr-therapeutics-present-42nd-annual-133000024.html
👍️0
JJ8 JJ8 1 년 전
Good morning OAG,

Surprising and interesting. Share price sudden "jack-rabbit" moves in quick price reversals. The technical picture for today changed from positive breakout yesterday to "High Pole Warning" with sudden drop in price. Apparently the dominating group of participants seem to dictate this pace a bit unusual and different from other stocks. Yet it offers opportunity for profit once one has a good plan and strategy.

Good you have a plan and strategy for your preferred limits and ranges for your trading. Let's see how it goes. Have fun & GLTY
👍️ 1

최근 히스토리

NASDAQ
CRSP
CRISPR Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지